Since dermatan sulfate is known to bind to a variety of signaling/adhesion molecules and growth factors [60], it is possible that endocan, through interacting with these cellular factors, can enhance angiogenesis in the NPC tumors. This evidence concerns the gene ESM1 and nasopharyngeal carcinoma.